Authors: Virgolini, I Traub, T Novotny, C Leimer, M Fuger, B Li, SR Patri, P Pangerl, T Angelberger, P Raderer, M Andreae, F Kurtaran, A Dudczak, R

Citation: I. Virgolini et al., New trends in peptide receptor radioligands, Q J NUCL M, 45(2), 2001, pp. 153-159

Authors: Traub, T Petkov, V Ofluoglu, S Pangerl, T Raderer, M Fueger, BJ Schima, W Kurtaran, A Dudczak, R Virgolini, I

Citation: T. Traub et al., In-111-DOTA-lanreotide scintigraphy in patients with tumors of the lung, J NUCL MED, 42(9), 2001, pp. 1309-1315

Authors: Virgolini, I Traub, T Leimer, M Novotny, C Pangerl, T Ofluoglu, S Halvadjieva, E Smith-Jones, P Flores, J Li, SR Angelberger, P Havlik, E Andreae, F Raderer, M Kurtaran, A Niederle, B Dubczak, R

Citation: I. Virgolini et al., New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy, Q J NUCL M, 44(1), 2000, pp. 50-58

Authors: Raderer, M Valencak, J Pfeffel, F Drach, J Pangerl, T Kurtaran, A Hejna, M Vorbeck, F Chott, A Virgolini, I

Citation: M. Raderer et al., Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type, J NAT CANC, 91(8), 1999, pp. 716-718

Authors: Smith-Jones, PM Bischof, C Leimer, M Gludovacz, D Angelberger, P Pangerl, T Peck-Radosavljevic, M Hamilton, G Kaserer, K Kofler, A Schlagbauer-Wadl, H Traub, T Virgolini, I

Citation: Pm. Smith-jones et al., DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy, ENDOCRINOL, 140(11), 1999, pp. 5136-5148